Ann: Positive IHL-675A in vivo results and FDA Pathway, page-50

Hi E - I was in the process of posting the same thoughts regarding the importance of that paragraph you have put up and the fact of it being overlooked. I also consider that the previous paragraph to the one you posted is vital as well :-

"Incannex anticipates to be granted an expedited Pre-IND meeting due to the Company’s intention to submit a FDA Emergency Use Authorisation request for patients with COVID-19"

Both paragraphs lean to what you say - Multi Billion Dollar Markets.